|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.03 USD | +10.93% |
|
0.00% | +16.67% |
| 27/06 | BioRestorative Therapies, Inc. Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program | CI |
| 13/06 | Top Midday Gainers | MT |
BioRestorative Therapies, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 0.035 million compared to USD 0.0313 million a year ago. Net loss was USD 2.22 million compared to USD 7.17 million a year ago.
Basic loss per share from continuing operations was USD 0.33 compared to USD 1.93 a year ago. Diluted loss per share from continuing operations was USD 0.33 compared to USD 1.93 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +16.67% | 1.37Cr | |
| +15.20% | 12TCr | |
| +19.67% | 11TCr | |
| +18.95% | 2.6TCr | |
| -23.86% | 1.94TCr | |
| -19.03% | 1.59TCr | |
| -20.90% | 1.51TCr | |
| -46.14% | 1.51TCr | |
| +63.85% | 1.49TCr | |
| +4.49% | 1.39TCr |
BIORESTORATIVE THERAPIES, INC. 
